NEW YORK ( TheStreet) -- Sequenom (Nasdaq: SQNM) hit a new 52-week low Monday as it is currently trading at $3.98, below its previous 52-week low of $4 with 2.3 million shares traded as of 2 p.m. ET. Average volume has been 2.2 million shares over the past 30 days. Sequenom has a market cap of $416.2 million and is part of the health care sector and drugs industry. Shares are down 48.1% year to date as of the close of trading on Friday. Sequenom, Inc. provides products, services, diagnostic testing, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural and livestock research.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter